Live Quote · NASDAQKYNBHealthcare· Biotechnology

Kyntra Bio, Inc.

$1.56▼ 14.72%($-0.27)
MKT CAP $6.32MNEXT EARNINGS Mar 15, 2027
50%
Bullish
TickerSpark Score
60/100
▌ Mixed
100
Valuation
65
Profitability
55
Growth
48
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KYNB research report →

Analyst Price Target
$28.00+1694.9% vs. today

Range $28 – $28

Analyst RatingHold
5 Buy8 Hold2 Sell

Price Chart

-78.60% · this period
$10.04$5.93$1.83Nov 19May 22Nov 19
52-Week Range0% of range
Low
$1.54
Current
$1.56
High
$10.47